Equity Overview
Price & Market Data
Price: $2.72
Daily Change: $0.00 / 0.00%
Daily Range: $2.31 - $2.96
Market Cap: $249,911,360
Daily Volume: 1,100,116
Performance Metrics
1 Week: 7.09%
1 Month: 4.62%
3 Months: 85.03%
6 Months: 180.4%
1 Year: 299.4%
YTD: 85.03%
Company Details
Employees: 15
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.